Cargando…
Wilms' Tumor Protein 1 and Enzymatic Oxidation of 5-Methylcytosine in Brain Tumors: Potential Perspectives
The patterns of 5-methylcytosine (5mC) and its oxidized derivatives, 5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxylcytosine (5caC) are reportedly altered in a range of cancers. Likewise, Wilms' Tumor protein 1 (WT1), a transcription factor essential for urogenital, epicardium, and ki...
Autores principales: | Ramsawhook, Ashley, Ruzov, Alexey, Coyle, Beth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874295/ https://www.ncbi.nlm.nih.gov/pubmed/29623275 http://dx.doi.org/10.3389/fcell.2018.00026 |
Ejemplares similares
-
Medulloblastoma and ependymoma cells display increased levels of 5-carboxylcytosine and elevated TET1 expression
por: Ramsawhook, Ashley, et al.
Publicado: (2017) -
CircCDYL Acts as a Tumor Suppressor in Wilms’ Tumor by Targeting miR-145-5p
por: Zhou, Rui, et al.
Publicado: (2021) -
The Methylation Game: Epigenetic and Epitranscriptomic Dynamics of 5-Methylcytosine
por: Alagia, Adele, et al.
Publicado: (2022) -
Integrative 5-Methylcytosine Modification Immunologically Reprograms Tumor Microenvironment Characterizations and Phenotypes of Clear Cell Renal Cell Carcinoma
por: Xu, Wenhao, et al.
Publicado: (2021) -
Molecular Characterization of the Clinical and Tumor Immune Microenvironment Signature of 5-methylcytosine-Related Regulators in non-small Cell Lung Cancer
por: Liu, Taisheng, et al.
Publicado: (2021)